Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Need help?

Patient Help Centre

Personalised care for women with diabetes in pregnancy

GDm-Health is a prescribed digital therapeutic for remote management of diabetes in pregnancy

GDm-Health is born out of clinical need and is underpinned by a rich source of clinical evidence, gathered as a result of extensive clinical evaluations. Listed on the NHS Digital Apps Library.

Patient Help Centre

The need for safe remote monitoring during the COVID-19 pandemic

The COVID-19 outbreak is now increasing the need for healthcare professionals to advocate self-monitoring to reduce face-to-face consultations for pregnant and postnatal women whilst maintaining care for the woman and her baby.

Benefits

Invented in the NHS

Invented in the NHS for the NHS, as a direct response to a clinical need. Designed by clinicians to be faster than pen and paper.

NHS approved

Listed on NHS Digital Apps Library. NICE approval expected imminently.

Reduces clinic visits

Self-management, combined with remote monitoring, gives pregnant women greater control of their diabetes and reduces the number of clinic visits.

Increases accuracy & speed

Improves the efficiency of the workflow by streamlining the process of communication between midwives and patients.

Secure

Anonymised patient data is securely stored on the cloud as a completely isolated instance with HSCN connectivity and rigorous data security and privacy.

Supports governance

Electronic capture of data enables detailed auditing of care and outcomes while supporting clinical governance.

This product is classified as a Class I medical device that complies with the essential requirements of Directive 93/42/EEC and following amendments.

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

Log blood glucose

The GDm-Health system comprises a smartphone app which connects to a wireless blood glucose (BG) meter using Bluetooth or NFC (Near Field Communication).

A woman’s measurements, along with any text-based commentary she wishes to log for call back, is then transmitted directly to a clinical dashboard for the multi-disciplinary team to proactively manage.

Enables prioritisation of patients

GDm-Health enables clinicians to see at a glance, near real-time blood glucose readings and prioritise care to women most in need whilst maintaining at a glance oversight of all patient cohorts.

Facilitates team-based working

GDm-Health improves the efficiency of the workflow by streamlining the process of communication between midwives and women. Communication between healthcare professionals through the patient’s GDM tailored digital record enhances team-based care.

Media

“Feedback from women using GDm-Health has been very positive. They like to know that their condition is being monitored, and appreciate the immediate feedback when their condition requires intervention from a clinician. It is particularly beneficial to women whose first language is not English, or who struggle with literacy. Being able to use an app rather than a handwritten log book and emails suits the current pregnant population – the millennial, but is very easy for everyone to use.”

RACHEL CROWLEY, Former DIABETES SPECIALIST MIDWIFE, ROYAL BERKSHIRE NHS FOUNDATION TRUST

Positive Clinical Trial Results

A 203 patient RCT shows use of GDm-Health was associated with:

16%

...reduction in women transitioning to pharmacological treatment*

64%

...reduction in pre-term birth*

42%

...reduction in caesarean sections

*Results did not reach statistical significance. Mackillop L, et al. JMIR Mhealth Uhealth 2018;6(3):e71

Satisfaction

Significantly higher patient satisfaction with care

(P=.049)

Compliance

Significantly better compliance with BG monitoring

Increased from 61% to 80% (P=.001)

In partnership with

Impact

1,312

C-sections prevented1

(30 April 2019: 765)

532

Pre-term births prevented1

(30 April 2019: 310)

10,361

Clinic visits saved2

(30 April 2019: 6,038)

835

Administrative hours saved2

(30 April 2019: 486)

1. Mackillop L, Hirst JE, Bartlett KJ, et al. Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018;6(3):e71.

2. GDm-Health for people with gestational diabetes - Medtech innovation briefing [MIB131] Published date: 13 November 2017 https://www.nice.org.uk/advice/mib131

A six month comparative study of GDm-Health at Royal Surrey Hospitals NHS Trust demonstrated transformative results, including:

21%

...reduction in mean time to intervention

47%

...reduction in the number of appointments with diabetes specialist doctors

100%

...of women using GDm-Health declared themselves happy with the care provided by the diabetes team

Featured case studies

Case study

Evaluating the potential for Sensyne in the US healthcare market – our collaboration with Jefferson Health

January 15, 2020

Case study

GDm-Health: a case study used by the NHS to demonstrate the direct benefit of data-driven innovation

October 7, 2019

Case study

Development of Sensyne Health's first clinical support algorithm

October 7, 2019

Publications

Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes

Randomized Controlled Trial

Novel Way to Deliver Care to Women with GDM through the Use of Cloud Technology

Conference Poster

GDm-Health for people with gestational diabetes

NICE Medtech innovation briefing

Disclaimer: Sensyne Health are not responsible for external website content.

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

Sensyne may have access to anonymous non-personal data generated in connection with the GDm-Health App. This data is only used for medical research purposes or for product improvement.

Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451

Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

In support of the ‘Understanding Patient Data’ initiative, Sensyne Health cite that its “work uses data provided by patients and collected by the NHS as part of their care and support”. #datasaveslives

Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

Personalised care for women with diabetes in pregnancy

GDm-Health is a prescribed digital therapeutic for remote management of diabetes in pregnancy

GDm-Health is born out of clinical need and is underpinned by a rich source of clinical evidence, gathered as a result of extensive clinical evaluations. Listed on the NHS Digital Apps Library.

The need for safe remote monitoring during the COVID-19 pandemic

Benefits

Invented in the NHS

NHS approved

Reduces clinic visits

Increases accuracy & speed

Secure

Supports governance

Log blood glucose

Enables prioritisation of patients

Facilitates team-based working

Media

Media

Media

Media

RACHEL CROWLEY, Former DIABETES SPECIALIST MIDWIFE, ROYAL BERKSHIRE NHS FOUNDATION TRUST

Positive Clinical Trial Results

A 203 patient RCT shows use of GDm-Health was associated with:

Satisfaction

Compliance

In partnership with

Impact

1,312

532

10,361

835

A six month comparative study of GDm-Health at Royal Surrey Hospitals NHS Trust demonstrated transformative results, including:

Featured case studies

Case study

January 15, 2020

Case study

October 7, 2019

Case study

October 7, 2019

Publications

CONTACT

FOLLOW US

EXPLORE

PRODUCTS

LEGAL

EXPLORE

PRODUCTS

Follow US

Legal

Contact